Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy

Transplantation
Leanne M SammelsM Beilharz

Abstract

Myoblast transfer therapy (MTT) is a cell-based gene therapy representing a potential treatment for Duchenne muscular dystrophy. The rapid disappearance of donor myoblasts from transplanted muscles after MTT is one of the most controversial and significant obstacles facing research in this area. Dystrophin-deficient muscles show constitutively high levels of inflammation, thus necessitating an examination of whether inflammatory cells, specifically natural killer (NK) cells, neutrophils, and macrophages, within dystrophic muscle are responsible for poor graft survival. Female mdx mice were treated with RB6-8C5 monoclonal antibody, PK136 monoclonal antibody, or clodronate liposomes to systemically deplete neutrophils, NK cells, and macrophages, respectively. After each depletion regimen, the mice and age-matched controls received 5.0 x 10 male myoblasts injected longitudinally into each tibialis anterior muscle. Donor myoblast survival was assessed by Y-chromosome specific quantitative real-time polymerase chain reaction analysis. RESULTS.: The systemic depletion of host neutrophils and NK cells resulted in a transient improvement in donor myoblast survival at 72 hr and 7 days post-MTT, respectively. Systemic depletion of macrop...Continue Reading

References

Mar 1, 1990·Journal of Leukocyte Biology·F G DelemarreN van Rooijen
Jan 1, 1984·Hybridoma·G C Koo, J R Peppard
Sep 14, 1994·Journal of Immunological Methods·N Van Rooijen, A Sanders
Feb 1, 1994·The Journal of Clinical Investigation·J HuardJ P Tremblay
Jul 1, 1996·Muscle & Nerve·Y FanM Grounds
Jun 3, 1998·Neuromuscular Disorders : NMD·H ItoJ P Tremblay
Sep 10, 1998·The Journal of Cell Biology·Z QuJ Huard
May 27, 1999·International Review of Cytology·S De la PorteJ Koenig
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·G M SmytheM D Grounds
Dec 9, 2000·Transplant International : Official Journal of the European Society for Organ Transplantation·K A van OverdamR L Marquet
Aug 30, 2001·Neuromuscular Disorders : NMD·M J Spencer, J G Tidball
May 22, 2002·The Journal of Cell Biology·Zhuqing Qu-PetersenJohnny Huard
Sep 11, 2002·Neuromuscular Disorders : NMD·Terry Partridge
Jan 10, 2003·Cell Transplantation·Daniel SkukJacques P Tremblay
Jan 15, 2004·Neuromuscular Disorders : NMD·Jean-Claude Kaplan

❮ Previous
Next ❯

Citations

Mar 24, 2006·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Olivier GheysensJoseph C Wu
Jul 27, 2007·Science in China. Series C, Life Sciences·Sheng YangJacques Menetrey
May 1, 1996·Enzyme and Microbial Technology·V M BalcãoF X Malcata
Dec 31, 2010·Transplantation·Kathryn L Pellegrini, Manfred W Beilharz
Jul 24, 2014·BioMed Research International·Sara Martina MaffiolettiFrancesco Saverio Tedesco
Oct 27, 2007·Pediatric Surgery International·Nathalie Hirt-BurriJudith Hohlfeld
Jan 6, 2011·Expert Opinion on Biological Therapy·Daniel Skuk, Jacques P Tremblay
Dec 2, 2004·Expert Opinion on Biological Therapy·Daniel Skuk
Feb 24, 2005·Neuromuscular Disorders : NMD·Nicolas HolzerJacques Menetrey
Aug 20, 2008·The American Journal of Pathology·Gregory Q WallaceElizabeth M McNally
Aug 30, 2005·Veterinary Immunology and Immunopathology·Thomas W VahlenkampWayne A F Tompkins
Jul 5, 2005·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Kristina R MuskiewiczEmanuela Gussoni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.